Endobronchial Donor Pre-Treatment With Ventavis: Is a Second Administration During Reperfusion Beneficial to Optimize Post-Ischemic Function of Non-Heart Beating Donor Lungs?

Journal of Surgical Research

Volumn 136, Issue 1, 2006, Pages 136-142

  Wittwer, Thorsten ^a   Franke, Ulrich F W ^b   Sandhaus, Tim ^b   Groetzner, Jan ^a   Strauch, Justus T ^a   Wippermann, Jens ^a   Ochs, Matthias ^c,d   Mühlfeld, Christian ^c   Börner, Angelika ^b   Streck, Sibylle ^b   Wahlers, Thorsten ^a  

^a UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

^d UNIVERSITY OF BERN   (Switzerland)

Author keywords

inhalative donor pre treatment; lung transplantation; non heart beating donors; Ventavis aerosolization

Indexed keywords

ILOPROST;

AEROSOL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOBRONCHIAL INTUBATION; FEMALE; HEART BEAT; LUNG; LUNG TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REPERFUSION; SWINE; SYSTOLIC BLOOD PRESSURE;

ADMINISTRATION, INHALATION; ANIMALS; ENDOTHELIN-1; EXTRAVASCULAR LUNG WATER; FEMALE; GRAFT SURVIVAL; HEART ARREST; ILOPROST; LUNG COMPLIANCE; LUNG TRANSPLANTATION; REPERFUSION INJURY; SUS SCROFA; TRANSPLANTATION CONDITIONING; VASCULAR RESISTANCE; VASODILATOR AGENTS;

EID: 33750362777     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.05.020     Document Type: Article

References (26)

1. Van Raemdonck D., Strüber M., Venuta F., Vlasselaers D., Wisser W., and Erasmus M.E. Strategies in the prevention and the treatment of ischemia-reperfusion injury after lung transplantation. Eur Respir Mon 29 (2004) 66
2. Trulock E.P., Edwards L.B., Taylor D.O., Boucek M.M., Keck B.M., and Hertz M.I. The Registry of The International Society for Heart and Lung Transplantation: Twenty-first official adult lung and heart-lung transplant report, 2004. J Heart Lung Transplant 23 (2004) 804
3. Curfman G.D. Hypothermia to protect the brain. N Engl J Med 346 (2002) 546
4. Boglione M.M., Morandini M.A., Barrenechea M.E., Rubio R.A., and Aguilar D. Pre-arrest heparinization and ventilation during warm ischemia preserves lung function in non-heart-beating donors. J Pediatr Surg 34 (1999) 1805
5. Koostra G., Daemen J.H., and Oomen A.P. Categories of non-heart-beating donors. Transplant Proc 27 (1995) 2893
6. Van Raemdonck D.E.M., Rega F.R., Neyrinck A.P., Jannis N., Verleden G.M., and Lerut T.E. Non-heart-beating donors. Semin Thorac Cardiovasc Surg 16 (2004) 309
7. D′Armini A.M., Roberts C.S., Griffith P.K., Lemasters J.J., and Egan T.M. When does the lung die?. I: Histochemical evidence of pulmonary viability after "death". J Heart Lung Transplant 13 (1994) 741
8. Rega F.R., Neyrinck A.P., Verleden G.M., Lerut T.E., and Van Raemdonck D.E.M. How long can we preserve the pulmonary graft inside the nonheart-beating donor?. Ann Thorac Surg 77 (2004) 438
9. Watanabe S., Sakasegawa K., Shimokawa S., Masuda H., and Sakata R. Intrathoracic cooling of cadavers before lung transplantation using cold air. Transplantation 73 (2002) 39
10. de Perrot M., and Keshavjee S. Lung preservation. Semin Thorac Cardiovasc Surg 16 (2004) 300
11. Gohrbandt B., Sommer S.P., Fischer S., et al. Iloprost to improve surfactant function in porcine pulmonary grafts stored for twenty-four hours in low-potassium dextran solution. J Thorac Cardiovasc Surg 129 (2005) 80
12. Fiser S.M., Cope J.T., Kron I.L., Kaza A.K., Long S.M., Kern J.A., and Tribble C.G. Aerosolized prostacyclin (Epoprostenol) as an alternative to inhaled nitric oxide for patients with reperfusion injury after lung transplantation. J Thorac Cardiovasc Surg 121 (2001) 981
13. Wittwer T., Franke U.F.W., Fehrenbach A., et al. Donor pretreatment using the aerosolized prostacyclin analogue iloprost optimizes postischemic function of non heart beating donor lungs. J Heart Lung Transplant 24 (2005) 371
14. Wittwer T., Franke U., Fehrenbach A., et al. Impact of retrograde graft preservation in perfadex-based experimental lung transplantation. J Surg Res 117 (2004) 239
15. Wittwer T., Franke U., Fehrenbach A., et al. Lung retrieval from non-heart-beating donors: First experience with an innovative preservation strategy in a pig lung transplantation model. Eur Surg Res 36 (2004) 1
16. Michel R.P., and Cruz-Orive L.M. Application of the Cavalieri principle and vertical sections method to the lung: Estimation of volume and pleural surface area. J Microsc 150 (1988) 117
17. Fehrenbach H. Alveolar epithelial type II cell: Defender of the alveolus revisited. Respir Res 2 (2001) 33
18. Fehrenbach A., Wittwer T., Fehrenbach H., Richter J., and Wahlers T. Pathological effects of nitric oxide on lung parenchyma after experimental ischemia and reperfusion. Thorac Cardiovasc Surg 49 Suppl 1 (2001) 61
19. Egan T.M. Non-heart-beating donor: Yes or no?. Ann Thorac Surg 70 (2000) 1451
20. Steen S., Sjöberg T., Pierre L., Liao Q., Eriksson L., and Algotsson L. Transplantation of lungs from a non-heart-beating donor. Lancet 357 (2001) 825
21. Inokawa H., Date H., Okazaki M., et al. Effects of postmortem hepartinization in canine lung transplantation with non-heart-beating donors. J Thorac Cardiovasc Surg 129 (2005) 429
22. Baretti R., Bitu-Moreno J., Beyersdorf F., Matheis G., Francischetti I., and Kreitmayr B. Distribution of lung preservation solutions in parenchyma and airways: influence of atelectasis and route of delivery. J Heart Lung Transplant 14 (1995) 80
23. Olschewski H., Ghofrani H.A., Walmrath D., et al. Inhaled prostycyclin and iloprost in severe pulmonary hytertension secondary to lung fibrosis. Am J Respir Crit Care Med 160 (1999) 600
24. Ikeda S., Shirai M., Shimouchi A., Min K.Y., Ohsawa N., and Ninomiya I. Pulmonary microvascular responses to inhaled prostacyclin, nitric oxide and their combination in anesthetized cats. Jpn J Physiol 49 (1999) 89
25. Fehrenbach A., Fehrenbach H., Wittwer T., Ochs M., Wahlers T., and Richter J. Evaluation of pulmonary edema: Stereological versus gravimetrical analysis. Eur Surg Res 33 (2001) 270
26. Strüber M., Wilhelmi M., Harringer W., et al. Flush perfusion with low potassium dextran solution improves early graft function in clinical lung transplantation. Eur J Cardiothorac Surg 19 (2001) 190